Form 4: Verastem Director John Johnson Adjusts Stock Option Holdings Through Exchange Program
SEC Form 4 Filing
Director John Johnson participated in Verastem's option exchange program, cancelling higher-priced options and receiving new options with a lower exercise price.
Summary
- On March 11, 2024, Verastem director John Johnson participated in the company's option exchange program.
- Johnson cancelled several existing stock options with exercise prices ranging from $15.60 to $49.92.
- In exchange, Johnson received 8,549 new stock options with an exercise price of $11.44.
- The new options vest in two equal installments over two years, starting March 11, 2024, contingent on continued service as a director or service provider.
- The cancelled options had been granted between January 2020 and June 2021, with varying vesting schedules.
Sentiment
Score: 5
Explanation: The document describes a routine transaction. It's neither particularly positive nor negative from an investment perspective.
Positives
- The option exchange program may incentivize the director with a lower exercise price, potentially aligning his interests with shareholders.
- The vesting schedule of the new options encourages continued service to the company.
Future Outlook
The director's future holdings will depend on the vesting of the new options and any subsequent transactions.
Industry Context
Option exchange programs are sometimes used to re-incentivize employees or directors when the stock price has fallen significantly below the exercise price of existing options.
Stakeholder Impact
- The option exchange could potentially impact shareholder value depending on the future performance of the stock and the director's actions.
Key Dates
| Date | Description |
|---|---|
| 01/03/2020 | Grant date of one of the cancelled stock option. |
| 04/29/2020 | Grant date of one of the cancelled stock option. |
| 06/16/2020 | Grant date of one of the cancelled stock option. |
| 06/28/2021 | Grant date of one of the cancelled stock option. |
| 03/11/2024 | Date of the option exchange and grant of new options. |
| 03/13/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.